Trial Outcomes & Findings for Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants (NCT NCT01389882)

NCT ID: NCT01389882

Last Updated: 2012-01-09

Results Overview

peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

26 participants

Primary outcome timeframe

four hours

Results posted on

2012-01-09

Participant Flow

Participants recruited from a neonatal intensive care unit (NICU) of Seoul National University Hospital, in Seoul, Republic of Korea between March 2011 to July 2011.

26 patients enrolled; 24 assigned to randomization and 2 excluded (1 extubated prior to the study and 1 developed exclusion criteria)

Participant milestones

Participant milestones
Measure
SN Group
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
NS Group
NAVA first, then SIMV with PS
Overall Study
STARTED
13
11
Overall Study
COMPLETED
12
7
Overall Study
NOT COMPLETED
1
4

Reasons for withdrawal

Reasons for withdrawal
Measure
SN Group
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
NS Group
NAVA first, then SIMV with PS
Overall Study
Respiratory rate > 80/min during study
1
3
Overall Study
Withdrawal by Subject
0
1

Baseline Characteristics

Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
SN Group
n=13 Participants
Synchronized intermittent mandatory ventilation (SIMV) with Pressure support (PS) first, then Neurally adjusted ventilatory assist (NAVA)
NS Group
n=11 Participants
NAVA first, then SIMV with PS
Total
n=24 Participants
Total of all reporting groups
Age Continuous
7 days
n=5 Participants
5 days
n=7 Participants
5 days
n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
0 Participants
n=7 Participants
7 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
11 Participants
n=7 Participants
17 Participants
n=5 Participants
Region of Enrollment
Korea, Republic of
13 participants
n=5 Participants
11 participants
n=7 Participants
24 participants
n=5 Participants
Gestational Age
206 days
STANDARD_DEVIATION 28 • n=5 Participants
212 days
STANDARD_DEVIATION 20 • n=7 Participants
209 days
STANDARD_DEVIATION 24 • n=5 Participants
Birth Weight
990 g
n=5 Participants
1630 g
n=7 Participants
1075 g
n=5 Participants
Birth Height
37.2 cm
STANDARD_DEVIATION 5.9 • n=5 Participants
38.3 cm
STANDARD_DEVIATION 6.7 • n=7 Participants
37.7 cm
STANDARD_DEVIATION 6.2 • n=5 Participants
Study Day Postmenstrual Age
220 days
STANDARD_DEVIATION 20 • n=5 Participants
222 days
STANDARD_DEVIATION 15 • n=7 Participants
221 days
STANDARD_DEVIATION 18 • n=5 Participants
Study Day Body Weight
1210 g
n=5 Participants
1530 g
n=7 Participants
1355 g
n=5 Participants
Capillary Blood pH
7.31 pH
STANDARD_DEVIATION 0.04 • n=5 Participants
7.34 pH
STANDARD_DEVIATION 0.06 • n=7 Participants
7.32 pH
STANDARD_DEVIATION 0.05 • n=5 Participants
Capillary Blood pCO2
48.83 mmHg
STANDARD_DEVIATION 8.93 • n=5 Participants
44.45 mmHg
STANDARD_DEVIATION 6.34 • n=7 Participants
46.8 mmHg
STANDARD_DEVIATION 8.00 • n=5 Participants
Capillary Blood pO2
37.77 mmHg
STANDARD_DEVIATION 7.03 • n=5 Participants
37.00 mmHg
STANDARD_DEVIATION 8.80 • n=7 Participants
37.42 mmHg
STANDARD_DEVIATION 7.72 • n=5 Participants
Capillary Blood HCO3
24.20 mmol/L
STANDARD_DEVIATION 3.45 • n=5 Participants
21.62 mmol/L
STANDARD_DEVIATION 9.34 • n=7 Participants
23.02 mmol/L
STANDARD_DEVIATION 6.78 • n=5 Participants

PRIMARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Peak Inspiratory Pressure
13.45 cmH2O
Standard Deviation 3.44
12.45 cmH2O
Standard Deviation 2.66

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

mean airway pressure measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Mean Airway Pressure
7.99 cmH2O
Standard Deviation 1.33
8.02 cmH2O
Standard Deviation 1.23

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Minute ventilation measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Minute Ventilation
0.53 L/min/Kg
Standard Deviation 0.15
0.51 L/min/Kg
Standard Deviation 0.11

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Expiratory tidal volume measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Expiratory Tidal Volume
8.73 mL/Kg
Standard Deviation 2.08
8.54 mL/Kg
Standard Deviation 2.24

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Dynamic Compliance measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Dynamic Compliance
1.70 mL/cmH2O
Standard Deviation 0.47
1.84 mL/cmH2O
Standard Deviation 0.36

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Work of breathing of patients measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Work of Breathing
11.13 mJ/L
Interval 3.92 to 60.79
8.38 mJ/L
Interval 1.6 to 30.21

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Peak electrical activity of the diaphragm

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Peak EAdi
13.39 uV
Standard Deviation 5.68
11.70 uV
Standard Deviation 5.72

SECONDARY outcome

Timeframe: four hours

Fraction of oxygen measured by a ventilator for 4 hours with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Fraction of Oxygen
23.33 percentage of concentration
Interval 21.08 to 41.18
23.47 percentage of concentration
Interval 20.75 to 39.07

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Capillary blood pH checked immediately after the 4-hour respiratory support with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Capillary Blood pH
7.327 pH
Standard Deviation 0.051
7.334 pH
Standard Deviation 0.046

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Capillary blood pCO2 checked immediately after the 4-hour respiratory support with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Capillary Blood pCO2
46.75 mmHg
Standard Deviation 7.43
46.64 mmHg
Standard Deviation 7.87

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Capillary blood pO2 checked immediately after the 4-hour respiratory support with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Capillary Blood pO2
38.89 mmHg
Standard Deviation 8.82
37.84 mmHg
Standard Deviation 8.51

SECONDARY outcome

Timeframe: four hours

Population: The analysis was "per protocol". 19 patients who had completed the study was used for the analysis.

Capillary blood HCO3 checked immediately after the 4-hour respiratory support with each ventilator mode

Outcome measures

Outcome measures
Measure
SIMV With PS
n=19 Participants
synchronized intermittent mandatory ventilation with pressure support
NAVA
n=19 Participants
neurally adjusted ventilatory assist
Capillary Blood HCO3
24.46 mmol/L
Standard Deviation 3.95
24.74 mmol/L
Standard Deviation 3.57

Adverse Events

SN Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

NS Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Juyoung Lee

Seoul National University Hospital

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place